Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study by Seyed Moayed Alavian, Mohammad Tasavon Gholamhoseini, Heidar Sharafi, Helena HL Borba, Asma Sabermahani, Behzad Hajarizadeh

Get full text

Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep studyResearch in context by Rugiatu Bah, Yumi Sheehan, Xiaoying Li, Gregory J. Dore, Jason Grebely, Andrew R. Lloyd, Behzad Hajarizadeh, Andrew Lloyd, Behzad Hajarizadeh, Yumi Sheehan, Rugi Bah, Charlotte Li, Marianne Byrne, Tony Butler, Bridget Musarurwa, Elmira Hooshmand, Annabeth Simpson, Meya Alrayyani, Jason Grebely, Greg Dore, Nikki Price, Melissa Groom

Get full text

Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics by Hossain M.S. Sazzad, Hui Li, Behzad Hajarizadeh, Bethany A. Horsburgh, Jason Grebely, Gregory J. Dore, Rowena A. Bull, Andrew R. Lloyd, Chaturaka Rodrigo

Get full text

Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia by Nicolas M. Legrand, Rowena A. Bull, Behzad Hajarizadeh, Andrew R. Lloyd, Kirsty Johnston, Katya Issa, Christine Harvey, Alicia Arnott, Dominic E. Dwyer, Vitali Sintchenko, Luke Grant, Gregory J. Dore, John Kaldor, Marianne Martinello

Get full text